These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 22073373)

  • 1. Cultured myoblasts from patients affected by myotonic dystrophy type 2 exhibit senescence-related features: ultrastructural evidence.
    Malatesta M; Giagnacovo M; Renna LV; Cardani R; Meola G; Pellicciari C
    Eur J Histochem; 2011; 55(3):e26. PubMed ID: 22073373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribonuclear inclusions and MBNL1 nuclear sequestration do not affect myoblast differentiation but alter gene splicing in myotonic dystrophy type 2.
    Cardani R; Baldassa S; Botta A; Rinaldi F; Novelli G; Mancinelli E; Meola G
    Neuromuscul Disord; 2009 May; 19(5):335-43. PubMed ID: 19345584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal muscle features in myotonic dystrophy and sarcopenia: do similar nuclear mechanisms lead to skeletal muscle wasting?
    Malatesta M
    Eur J Histochem; 2012 Aug; 56(3):e36. PubMed ID: 23027352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Premature senescence in primary muscle cultures of myotonic dystrophy type 2 is not associated with p16 induction.
    Renna LV; Cardani R; Botta A; Rossi G; Fossati B; Costa E; Meola G
    Eur J Histochem; 2014 Oct; 58(4):2444. PubMed ID: 25578974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutant (CCTG)n expansion causes abnormal expression of zinc finger protein 9 (ZNF9) in myotonic dystrophy type 2.
    Raheem O; Olufemi SE; Bachinski LL; Vihola A; Sirito M; Holmlund-Hampf J; Haapasalo H; Li YP; Udd B; Krahe R
    Am J Pathol; 2010 Dec; 177(6):3025-36. PubMed ID: 20971734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of muscle atrophy in myotonic dystrophies.
    Timchenko L
    Int J Biochem Cell Biol; 2013 Oct; 45(10):2280-7. PubMed ID: 23796888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle pathology in myotonic dystrophy: light and electron microscopic investigation in eighteen patients.
    Nadaj-Pakleza A; Lusakowska A; Sułek-Piątkowska A; Krysa W; Rajkiewicz M; Kwieciński H; Kamińska A
    Folia Morphol (Warsz); 2011 May; 70(2):121-9. PubMed ID: 21630234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA/MBNL1-containing foci in myoblast nuclei from patients affected by myotonic dystrophy type 2: an immunocytochemical study.
    Perdoni F; Malatesta M; Cardani R; Giagnacovo M; Mancinelli E; Meola G; Pellicciari C
    Eur J Histochem; 2009 Sep; 53(3):151-8. PubMed ID: 19864209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for PLCβ1 in myotonic dystrophies type 1 and 2.
    Faenza I; Blalock W; Bavelloni A; Schoser B; Fiume R; Pacella S; Piazzi M; D'Angelo A; Cocco L
    FASEB J; 2012 Jul; 26(7):3042-8. PubMed ID: 22459146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of a differentiation defect in muscle satellite cells from DM2 patients.
    Pelletier R; Hamel F; Beaulieu D; Patry L; Haineault C; Tarnopolsky M; Schoser B; Puymirat J
    Neurobiol Dis; 2009 Oct; 36(1):181-90. PubMed ID: 19632331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA/MBNL1-containing foci in myoblast nuclei from patients affected by myotonic dystrophy type 2: an immunocytochemical study.
    Perdoni F; Malatesta M; Cardani R; Giagnacovo M; Mancinelli E; Meola G; Pellicciari C
    Eur J Histochem; 2009 Sep; 53(3):e18. PubMed ID: 30256871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immortalized human myotonic dystrophy muscle cell lines to assess therapeutic compounds.
    Arandel L; Polay Espinoza M; Matloka M; Bazinet A; De Dea Diniz D; Naouar N; Rau F; Jollet A; Edom-Vovard F; Mamchaoui K; Tarnopolsky M; Puymirat J; Battail C; Boland A; Deleuze JF; Mouly V; Klein AF; Furling D
    Dis Model Mech; 2017 Apr; 10(4):487-497. PubMed ID: 28188264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-segregation of DM2 with a recessive CLCN1 mutation in juvenile onset of myotonic dystrophy type 2.
    Cardani R; Giagnacovo M; Botta A; Rinaldi F; Morgante A; Udd B; Raheem O; Penttilä S; Suominen T; Renna LV; Sansone V; Bugiardini E; Novelli G; Meola G
    J Neurol; 2012 Oct; 259(10):2090-9. PubMed ID: 22407275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of the rate of protein translation in patients with myotonic dystrophy 2.
    Huichalaf C; Schoser B; Schneider-Gold C; Jin B; Sarkar P; Timchenko L
    J Neurosci; 2009 Jul; 29(28):9042-9. PubMed ID: 19605641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24.
    Le Ber I; Martinez M; Campion D; Laquerrière A; Bétard C; Bassez G; Girard C; Saugier-Veber P; Raux G; Sergeant N; Magnier P; Maisonobe T; Eymard B; Duyckaerts C; Delacourte A; Frebourg T; Hannequin D
    Brain; 2004 Sep; 127(Pt 9):1979-92. PubMed ID: 15215218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanded [CCTG]n repetitions are not associated with abnormal methylation at the CNBP locus in myotonic dystrophy type 2 (DM2) patients.
    Santoro M; Fontana L; Maiorca F; Centofanti F; Massa R; Silvestri G; Novelli G; Botta A
    Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):917-924. PubMed ID: 29291944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomolecular identification of (CCTG)n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy.
    Cardani R; Mancinelli E; Sansone V; Rotondo G; Meola G
    Eur J Histochem; 2004; 48(4):437-42. PubMed ID: 15718211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA processing is altered in skeletal muscle nuclei of patients affected by myotonic dystrophy.
    Malatesta M; Giagnacovo M; Cardani R; Meola G; Pellicciari C
    Histochem Cell Biol; 2011 Apr; 135(4):419-25. PubMed ID: 21387185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myotonic dystrophy: emerging mechanisms for DM1 and DM2.
    Cho DH; Tapscott SJ
    Biochim Biophys Acta; 2007 Feb; 1772(2):195-204. PubMed ID: 16876389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative splicing of human insulin receptor gene (INSR) in type I and type II skeletal muscle fibers of patients with myotonic dystrophy type 1 and type 2.
    Santoro M; Masciullo M; Bonvissuto D; Bianchi ML; Michetti F; Silvestri G
    Mol Cell Biochem; 2013 Aug; 380(1-2):259-65. PubMed ID: 23666741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.